When considering wrinkle reduction treatments, understanding the different types of Botox available helps you make informed decisions about your aesthetic goals. While "Botox" is often used as a generic term for botulinum toxin injections, six distinct FDA-approved formulations offer unique benefits for addressing dynamic wrinkles and promoting facial rejuvenation.

From our Seoul-based practice, we've witnessed the transformative effects of selecting the right botulinum toxin treatment based on individual skin characteristics, treatment areas, and aesthetic objectives, helping over 15,000 satisfied customers achieve their desired results with our authentic Korean beauty expertise.

Table of Contents

What Are Neurotoxins?

Neurotoxins represent a revolutionary class of injectable treatments that temporarily reduce muscle activity, causing dynamic wrinkles. These botulinum toxin brands contain botulinum toxin type A, a purified protein derived from the bacterium Clostridium botulinum, which works by blocking nerve signals to targeted facial muscles.

When injected precisely into specific muscles, neurotoxins prevent the release of acetylcholine—a neurotransmitter responsible for muscle contraction—resulting in smoother, more youthful-appearing skin.

The mechanism involves the toxin binding to nerve terminals at neuromuscular junctions, where it cleaves proteins essential for the release of neurotransmitters. This creates temporary chemodenervation lasting 3-4 months, depending on the formulation used.

Unlike dermal fillers that add volume to static wrinkles, neurotoxin injections specifically target movement-related lines, including crow's feet, forehead furrows, and frown lines between the eyebrows.

The 6 FDA-Approved Neurotoxin Brands

dysport and xeomin

Dysport (AbobotulinumtoxinA)

  • FDA Approval and History: Approved by the FDA for glabellar lines in 2009, Dysport originated from European markets, where it had gained extensive clinical experience before its introduction in the US. Manufactured by Galderma, it represents the first major alternative to Botox in the American market.
  • How It Works: Dysport's smaller complex size, estimated to be between 500 and 900 kDa, contributes to its broader diffusion from the injection site. This characteristic enables fewer injection points to cover larger treatment areas, which is particularly beneficial for expansive regions, such as the forehead. The same active ingredient as other neurotoxins works to treat frown lines and forehead wrinkles.
  • Duration and Results: Effects typically last 3-4 months, though some patients report slightly extended duration. Onset occurs rapidly, within 24-48 hours, with peak effects achieved by day 3-5, which is faster than most competitors.
  • Best For: Large treatment areas requiring broad coverage, such as horizontal forehead lines. Its rapid onset benefits patients seeking quick results for special events or occasions. Our Dysport 500 offers an authentic formulation, accompanied by temperature-controlled shipping, to ensure maximum potency and efficacy.

Xeomin (IncobotulinumtoxinA)

  • FDA Approval and History: Approved in 2011, Xeomin distinguishes itself as the first "naked" neurotoxin without complex proteins. Developed by Merz Pharmaceuticals, it offers unique advantages for specific patient populations seeking cosmetic treatments.
  • How It Works: Xeomin contains only the purified 150 kDa neurotoxin core, without accessory proteins, thereby reducing the antigenic load and the theoretical risk of immunogenicity. This formulation creates diffusion patterns similar to those of Botox, while minimizing protein exposure at the injection site.
  • Duration and Results: The duration matches that of Botox, at 3-4 months, with onset at 3-5 days and peak effects at 10-14 days. Studies show comparable efficacy to Botox across multiple facial regions for reducing wrinkles.
  • It is best for Patients with protein allergies, those with a history of neurotoxin resistance, or those requiring long-term maintenance therapy. Its room-temperature stability before reconstitution offers logistical advantages for cosmetic use. Our Xeomin 100U offers a comparable alternative with reduced protein content for sensitive patients.

Botox (OnabotulinumtoxinA)

  • FDA Approval and History: Botox Cosmetic received its first cosmetic approval in 2002 for glabellar lines, with subsequent approvals expanding to include crow's feet (2013) and forehead lines (2017). Developed by Allergan, it remains the most extensively researched neurotoxin, with over two decades of safety data.
  • How It Works: Botox contains a 900 kDa molecular complex with accessory proteins that stabilize the core neurotoxin. These complex proteins may influence binding specificity and diffusion characteristics, creating relatively localized effects ideal for precise treatments. The active ingredient works by temporarily blocking nerve signals to facial muscles.
  • Duration and Results: The typical duration ranges from 3 to 4 months for cosmetic applications, with initial effects visible within 3 to 5 days and peak results typically achieved in 10 to 14 days. Clinical studies show most patients maintain significant improvement at 12 weeks post-treatment.
  • Best For: Precision treatments in areas requiring controlled diffusion, such as periorbital zones. Its predictable outcomes make it excellent for first-time patients or those seeking conservative enhancement.

Jeuveau (PrabotulinumtoxinA-xvfs)

  • FDA Approval and History: The newest traditional neurotoxin, approved in 2019, is specifically indicated for the treatment of severe frown lines. Developed by Evolus, Jeuveau positions itself as a modern alternative with competitive pricing.
  • How It Works: Jeuveau's molecular structure and formulation closely resemble Botox, utilizing similar complexing proteins and molecular weight characteristics. This creates comparable diffusion and binding properties for treating moderate to severe facial wrinkles.
  • Duration and Results: The duration and onset of Botox are similar, with a total effect of 3-4 months, an onset of 3-5 days, and peak results at 10-14 days. Medical trials demonstrate non-inferiority to established neurotoxins for cosmetic purposes.
  • Best For: Cost-conscious patients seeking proven neurotoxin results at competitive pricing. Its familiar profile makes it suitable for many patients who are comfortable with Botox-like characteristics.

Daxxify (DaxibotulinumtoxinA-lanm)

  • FDA Approval and History: Approved by the FDA in 2022, Daxxify represents the most significant advancement in neurotoxin technology in decades. Developed by Revance Therapeutics using novel peptide stabilization technology for cosmetic dermatology applications.
  • How It Works: Daxxify incorporates RTP004, a proprietary stabilizing peptide that enhances neuronal membrane binding through electrostatic interactions. This innovation extends duration without increasing immunogenicity compared to traditional complexing proteins that contain human serum albumin.
  • Duration and Results: Revolutionary 6-month duration in clinical trials, approximately double traditional neurotoxins. Onset occurs rapidly at 1-2 days, providing both speed and longevity advantages for treating severe lines.
  • Best For: Patients prioritizing extended intervals between treatments and rapid results. It is ideal for busy lifestyles requiring minimal maintenance frequency and temporary aesthetic treatment benefits.

Letybo (LetibotulinumtoxinA)

  • FDA Approval and History: The newest addition, approved in March 2024 for glabellar lines, after extensive international use. Manufactured by Hugel Inc., it brings proven global experience to the US market as an FDA-approved neurotoxin.
  • How It Works: Letybo utilizes a "naked" formulation, similar to Xeomin, which contains only purified neurotoxin without complexing proteins. This approach reduces immunogenic potential while maintaining efficacy for cosmetic treatments.
  • Duration and Results: The duration aligns with traditional neurotoxins, at 3-4 months, featuring a rapid onset of 2-3 days, among the fastest available. Clinical trials show 65% treatment success rates for temporary improvement.
  • Best for: Patients seeking rapid onset with minimal immunogenicity risk, particularly those with protein sensitivities or a history of neurotoxin resistance, who require board-certified treatment approaches.

Types of Botox Comparison Table

Product

Onset Time

Duration

Molecular Weight/Complex Size

Protein Content

Best Applications

Botox

3-5 days

3-4 months

900 kDa

High

Precision treatments, crow's feet

Dysport

1-2 days

3-4 months

500-900 kDa

Medium

Large areas, forehead lines

Xeomin

3-5 days

3-4 months

150 kDa

None

Allergic patients, resistant cases

Jeuveau

3-5 days

3-4 months

900 kDa

High

Cost-effective alternative

Daxxify

1-2 days

6 months

150 kDa + peptide

Low

Extended duration seekers

Letybo

2-3 days

3-4 months

150 kDa

None

Rapid onset, sensitive patients

Individual results may vary based on metabolism, muscle strength, and dosing, with some patients experiencing shorter or longer effects across all formulations.

Key Differences Between Neurotoxin Brands

Molecular Weight and Formulation

Molecular architecture significantly influences clinical performance across neurotoxin brands. Botox and Jeuveau utilize large 900 kDa molecular complexes containing accessory proteins that stabilize the core toxin but increase the antigenic load.

These complex proteins affect diffusion characteristics, creating more localized effects suitable for precision applications. Conversely, Xeomin and Letybo employ "naked" 150 kDa formulations containing only purified neurotoxin, reducing protein exposure by approximately 85% compared to complexed versions.

Dysport occupies a middle ground, with a complex size of approximately 500–900 kDa and a moderate level of accessory proteins. Its formulation allows for broader diffusion, making it well-suited for large treatment areas, such as the forehead. Daxxify innovates by combining the 150 kDa core toxin with RTP004 peptide stabilization, achieving extended duration through enhanced neuronal binding rather than protein complexing.

Protein Content

Protein content directly correlates with the risk of immunogenicity and storage requirements.

High-protein formulations (Botox, Jeuveau) contain approximately five ng protein per 100 units, while protein-free versions (Xeomin, Letybo) reduce this to 0.6 ng—an 88% reduction. This dramatic decrease theoretically lowers neutralizing antibody development, which is particularly important for long-term therapy requiring decades of maintenance treatments.

Dysport contains moderate protein levels and includes lactose as a stabilizer, along with trace amounts of cow’s milk protein. These components may pose a risk for individuals with milk protein allergies or lactose intolerance, creating potential contraindications in sensitive patients. Daxxify's peptide technology achieves protein reduction while extending duration, representing optimal advancement in formulation science.

Onset Time

Onset variations arise from molecular size and formulation differences that affect tissue penetration and binding to the neuromuscular junction.

Dysport demonstrates the fastest traditional onset, at 24-48 hours, due to its smaller molecular size, which facilitates rapid diffusion. Daxxify achieves even faster results, typically within 1-2 days, through enhanced binding kinetics resulting from peptide stabilization.

Botox, Xeomin, and Jeuveau exhibit an intermediate onset at 3-5 days, while Letybo's rapid 2-3 day timeline positions it competitively despite its recent market entry.

Patient factors, including injection technique, dose concentration, and individual metabolism, influence these timelines, with actual results potentially varying by 1-2 days from published averages.

Duration

Duration represents the most significant differentiator among modern neurotoxins. Traditional formulations (Botox, Dysport, Xeomin, Jeuveau, Letybo) typically provide 3-4 months of clinical benefit at standard dosing, with individual variation based on metabolism, muscle mass, and previous treatment history.

Daxxify revolutionizes duration expectations with consistent 6-month results in medical trials, attributed to its proprietary peptide technology, which enhances neuronal binding stability. This extended timeline reduces annual treatment frequency from 3-4 sessions to 2, potentially improving patient compliance and satisfaction while reducing cumulative costs despite higher per-treatment pricing.

Diffusion Patterns

Diffusion characteristics determine optimal applications for each neurotoxin. Botox and Xeomin create relatively contained spread patterns, making them ideal for periorbital treatments, where precision prevents complications such as eyelid ptosis. Their controlled diffusion enables safe use near delicate structures while maintaining efficacy.

Dysport's broader diffusion covers larger areas with fewer injection points but requires careful placement to avoid unintended muscle effects—this characteristic benefits forehead treatment, where uniform coverage improves aesthetic outcomes. Intermediate diffusion patterns of Jeuveau, Daxxify, and Letybo offer versatility across multiple facial regions.

Cost Differences

Pricing varies significantly among neurotoxin brands, influenced by manufacturing costs, research investments, and market positioning.

While we don't disclose specific pricing due to market fluctuations, patients can explore competitive options through our rewards program, which offers additional value to loyal customers.

Our blog readers can also save with the discount code meamoblog for 12.5% off their first order, making premium Korean neurotoxins more accessible.

Treatment outcomes may vary depending on factors such as metabolism, muscle tone, and dosage, with the duration of treatment differing among individuals across all formulations.

Which Type of Botox Is Right for You?

Selecting the optimal neurotoxin requires a comprehensive evaluation of multiple factors, including treatment goals, anatomical considerations, lifestyle preferences, and medical conditions. Our Seoul-based expertise with diverse patient populations has revealed key decision criteria that consistently predict treatment satisfaction and optimal outcomes.

Treatment Area Specificity plays a crucial role in product selection, for precision-required zones, such as crow's feet or the upper lip, where controlled diffusion is necessary to prevent complications, Botox or Xeomin excel due to their localized spread patterns. Large areas, such as forehead lines, benefit from Dysport's broader diffusion, which reduces the number of injection points while achieving uniform coverage. Mid-face applications requiring intermediate diffusion favor Jeuveau, Daxxify, or Letybo.

Timeline Expectations significantly influence satisfaction. Patients with upcoming events may benefit from rapid-onset options, such as Dysport (24-48 hours), Daxxify (1-2 days), or Letybo (2-3 days). Those comfortable with traditional timelines can choose from the full range, while seekers of extended durations should prioritize Daxxify despite the higher initial costs.

Individual Medical Factors create specific contraindications and preferences. Patients with protein allergies require Xeomin or Letybo's naked formulations. Individuals with cow’s milk protein allergies should avoid Dysport due to its formulation containing trace amounts of milk-derived proteins. Previous neurotoxin resistance suggests switching to protein-free alternatives, such as Xeomin.

Long-term maintenance patients benefit from low-immunogenicity options to prevent antibody development. Additionally, individuals using botulinum type products for therapeutic purposes, such as treating muscle spasms, may require dosage adjustments or alternative formulations tailored to their specific medical needs, rather than for cosmetic purposes.

Our Baby Botox Collagen Booster Set exemplifies innovative Korean approaches to neurotoxin therapy, combining precision dosing with collagen stimulation for naturally enhanced results. This comprehensive system includes Liztox 100U, paired with our proprietary Hydra Stamp device and Miracle H skin booster, delivering personalized microdoses that smooth dynamic wrinkles while avoiding the "frozen" appearance associated with traditional high-dose treatments.

How to Choose Between Different Neurotoxin Brands

Skin Type & Age Considerations

Skin characteristics significantly influence the selection and dosing strategies for neurotoxins. Thicker skin types, commonly associated with higher collagen density and a robust dermal structure, often require more units to achieve the desired effects compared to thinner skin phenotypes.

Younger patients (in their late 20s to early 30s) seeking preventative treatments typically require lower doses with strategic placement in high-movement zones to minimize dynamic line formation before static wrinkles develop. Our innovative MeamoLabs formulations offer cutting-edge solutions specifically designed for preventative and maintenance treatments, reflecting the latest advances in Korean skincare technology.

Middle-aged patients (40s-60s) represent the core demographic for comprehensive multi-area treatments with moderate dosing to address established dynamic lines and early static wrinkles. Mature patients (65 years and older) may exhibit reduced muscle mass and thinner skin, potentially requiring adjusted dosing strategies while demonstrating faster onset times due to age-related neuromuscular changes. Many patients in this age group benefit from minimally invasive approaches to achieve smoother skin and improved skin texture.

Treatment History & Response Patterns

Previous neurotoxin experience provides valuable guidance for future treatments. Patients who experience an excellent response to a specific brand should typically continue with the proven formulation unless contraindications arise. In cases involving dermatologic surgery, prior exposure and healing response may also influence product selection and dosing strategies.

Treatment-naive patients benefit from conservative initial dosing with established products, allowing assessment of individual muscle function and response patterns before exploring specialized formulations. Our comprehensive botulinum toxin collection offers multiple options to find the perfect match for individual needs and treatment goals.

Effects may vary by individual depending on muscle strength, metabolism, and dosage across all formulations.

International Alternatives: Korean Neurotoxins

While the six FDA-approved neurotoxins dominate the U.S. market, international alternatives, such as Hejeubo, are gaining popularity among experienced practitioners. Manufactured in South Korea, Hejeubo 100U is a botulinum toxin type A formulation known for its smooth diffusion and consistent cosmetic outcomes.

Also read: Benefits of Korean Botox

Jeunetique EXO

(119)
Price range: $38.40 through $151.20
Earn up to 7 Points
Select options This product has multiple variants. The options may be chosen on the product page

 Download Brochure

An innovative skinbooster based on the rejuvenating action of exosomes at the subcellular level. The action of Meamo Jeunetique Exo is based on the introduction of active signaling molecules into the dermis using exosomes. The anti-aging properties of Meamo Jeunetique Exo are enhanced by the inclusion of polydesoxyribonucleotide (PDRN), atelocollagen, cellular growth factors and ultra-short peptides.
Exosomes Icon Exosomes Enhance cellular communication, accelerating skin repair and reducing inflammation.
PDRN Icon PDRN Drives deep cellular regeneration, renewing and revitalizing your complexion.
Collagen Regeneration Icon Collagen & Peptides Boost elasticity and hydration, smoothing fine lines and restoring firmness.

héjeubo 100U (EXP: 2026.07.25)

(44)
Price range: $45.50 through $291.20
Earn up to 14 Points
Read More This product has multiple variants. The options may be chosen on the product page

 Download Brochure

héjeubo is an advanced injectable treatment designed to reduce wrinkles and fine lines on the face and neck. Using Clostridium botulinum toxin type A, it temporarily blocks muscle activity, smoothing out wrinkles caused by facial expressions. Developed with a focus on safety and effectiveness, héjeubo is verified for potency, efficacy, and manufacturing quality. It provides a smooth, comfortable injection process and long-lasting results, with minimal to no side effects. Ideal for enhancing youthful skin, it guarantees visible improvements in as little as 3-5 days.

Key Benefits

  • Proven Potency & Safety: Manufactured under strict quality standards, ensuring high efficacy and minimal side effects.
  • Efficient Production Method: Utilizes the "Botulinum toxin-specific Vacuum Drying" technique for quick, uniform powder reconstitution, enhancing effectiveness.
  • Long-Lasting Results: Visible effects within 3-5 days, with results lasting up to 6 months, reducing the need for frequent treatments.

BEAUY Collagen Stimulator (PLLA)

(34)
Original price was: $139.00.Current price is: $111.00.
Earn 5 Points
Add to cart

 Download Brochure

BEAUY is a next-generation powder-type collagen stimulator made with PLA and SCMC, designed to stimulate natural collagen production for long-lasting volume and skin rejuvenation. With its biodegradable microspheres and smooth injection properties, BEAUY offers a safe, effective alternative to traditional fillers—delivering results that can last up to 24 months.
Under-eye area Perfect spherical shape Uniform microspheres ensure smooth application, consistent performance, and natural results.
Wrinkle removal Ease of preparation Freeze-dried powder dissolves quickly, reducing prep time and streamlining treatments.
Safe formula Biodegradable Components Made from PLA polymer that fully decomposes in the body through natural metabolism.

BEAUX Collagen Stimulator (PDLLA/HA)

(31)
Original price was: $129.00.Current price is: $103.00.
Earn 5 Points
Add to cart

 Download Brochure

BEAUX is a cutting-edge powder-type collagen stimulator that combines 150 mg of PDLLA (Poly-D,L-lactic Acid) with 50 mg of Hyaluronic Acid (HA) to deliver both immediate volumizing effects and long-term collagen regeneration. Designed with Smart SPDS™ Technology, BEAUX microspheres are perfectly spherical and uniformly sized, ensuring consistent decomposition and exceptional safety.
Under-eye area Perfect spherical shape Uniform microspheres ensure smooth application, consistent performance, and natural results.
Wrinkle removal Ease of preparation Freeze-dried powder dissolves quickly, reducing prep time and streamlining treatments.
Safe formula Biodegradable Components Made from PDLLA polymer that fully decomposes in the body through natural metabolism.

Frequently Asked Questions

What is the difference between Botox and other neurotoxins?

While all neurotoxins contain the same active ingredient (botulinum toxin type A), they differ in molecular formulation, protein content, and clinical characteristics. Botox contains complex proteins creating localized effects, while Xeomin and Letybo use "naked" formulations without accessory proteins. Dysport features smaller molecules, enabling broader diffusion, and Daxxify incorporates peptide technology for an extended duration. These differences affect onset time (1-5 days), duration (3-6 months), and optimal applications for specific facial areas.

Which type of Botox lasts the longest?

Daxxify demonstrates the longest duration of effect used in Botox treatments, maintaining effects for approximately 6 months, compared to 3–4 months for traditional options. Medical trials show 50–60% of Daxxify patients, often treated by a cosmetic surgeon, retain significant improvement at 24 weeks post-treatment. This extended duration is attributed to proprietary peptide stabilization technology that enhances neuronal binding, making it a compelling option in both clinical and aesthetic dermatology. Daxxify is also the only botulinum toxin type formulated with this innovative peptide, which is being explored for therapeutic use in conditions such as muscle spasticity.

Is Dysport better than Botox for treating glabellar lines?

Neither product is universally superior; the optimal choice depends on treatment goals and individual factors. Our Dysport 500 offers a faster onset (24-48 hours vs. 3-5 days) and broader diffusion, making it ideal for large areas, such as the forehead. However, its wider spread requires careful placement near delicate structures. Botox provides more predictable and localized effects, making it suitable for precise treatments. Both demonstrate similar duration (3-4 months) and safety profiles when dosed appropriately.

What makes Xeomin different from other neurotoxins?

Xeomin's distinguishing feature is its "naked" formulation, which contains only purified 150 kDa neurotoxin without complexing proteins. This reduces the protein load by approximately 85% compared to Botox, theoretically lowering the immunogenicity risk and making it suitable for patients with protein allergies or a history of neurotoxin resistance. Despite its simplified composition, Xeomin effectively targets facial expressions that contribute to the development of fine lines and wrinkles, delivering results comparable to those of other leading neurotoxins.

Can neurotoxins treat excessive sweating?

Yes, several neurotoxins are FDA-approved for treating excessive sweating (hyperhidrosis), particularly in the underarm area. The treatment works by blocking nerve signals to sweat glands, significantly reducing excessive underarm sweating for 6-12 months. This medical application demonstrates the versatility of botulinum toxin products beyond cosmetic uses.

Can you switch between different neurotoxin brands?

Yes, switching between neurotoxin brands is generally safe when performed by qualified practitioners. However, several considerations apply: dosing conversions between brands (particularly Dysport, which requires a 2.5-3:1 ratio from Botox units), allowing for the complete elimination of previous toxin before switching (typically 3-6 months) and monitoring for different response patterns.

Key Takeaways

Understanding the six FDA-approved types of botulinum neurotoxins empowers informed decision-making for achieving aesthetic enhancement goals. Each formulation—Botox, Dysport, Xeomin, Jeuveau, Daxxify, and Letybo—offers distinct advantages based on molecular characteristics, onset timing, and duration profiles.

Effective Botox injections address fine lines and moderate to severe glabellar wrinkles by targeting the facial muscles responsible for vertical lines and other signs of aging at their source.

Whether treating the masseter muscle for jaw slimming or addressing forehead wrinkles for smoother skin, plastic surgeons emphasize that understanding facial anatomy is essential for achieving optimal results. These cosmetic treatments offer temporary improvements for lines and wrinkles, with effects that can take up to two weeks to develop fully.

Citations:
[1] https://www.specialistsinplasticsurgery.com/blog/botox-vs-xeomin-vs-dysport/
[2] https://www.plasticsurgery.org/news/articles/how-does-daxxify-compare-to-botox

Share this post on social media

Like this post

Copyright © 2024 Meamo Co. Ltd. All Rights Reserved.

No part of this publication may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the author, except in the case of brief quotations embodied in critical reviews and certain other noncommercial uses permitted by copyright law. For permission requests, write to the author, addressed “Attention: Permissions Coordinator,” at the address below.

Contact email: Support@meamo.co

Related Posts

What are PN and PDRN?

Polynucleotides – without exaggeration, one of the major breakthroughs in cosmetology in recent years. However, when discussing these products, two

Read More